Rev. Méd. Inst. Mex. Seguro Soc; 59 (4), 2021
Publication year: 2021
Introducción:
en México 130 000 personas viven con enfermedad renal crónica (ERC). Las afecciones cardiacas son los problemas clínicos más frecuentes; 45% de las muertes de pacientes en terapia sustitutiva tienen un origen cardiaco. Objetivo:
identificar la probabilidad de presentar falla cardiaca aguda (FCA) en pacientes con ERC en el Servicio de Urgencias Adultos de un hospital de segundo nivel. Material y métodos:
estudio de casos (111) y controles (103). Los casos se definieron como pacientes con ERC ingresados a Urgencias por FCA comparados con controles, pacientes con ERC que ingresaron por otro diagnóstico diferente. Se realizó regresión logística binaria y se determinaron razones de momios (RM) e intervalos de confianza al 95% (IC 95%). Un valor de p ˂ 0.05 fue significativo. Resultados:
la hipertensión arterial (RM 7.12, IC 95% 2.3-22.06, p = 0.01), el uso de 3 o más antihipertensivos (RM, 2.903, IC 95% 1.19-7.11, p = 0.02), empleo de inhibidores de la enzima convertidora de angiotensina (IECA) (RM 4.25, IC 95% 1.78-10.09, p = 0.01), antagonistas de los receptores de angiotensina-II (ARA-II) (RM 2.41, IC 95% 1.19-4.89, p = 0.014), diuréticos (RM 42.87, IC 95% 9.02-203.63, p = 0.00), diálisis peritoneal (RM 2.48, IC 95% 1.25-4.81, p = 0.009) y hemodiálisis (RM 0.40, IC 95% 0.20-0.79, p = 0.009) tuvieron significación estadística. Conclusiones:
los pacientes con ERC con hipertension arterial, empleo de IECA, ARA-II, diuréticos y en dialisis peritoneal, tuvieron mayor probabilidad de presentar falla cardiaca aguda, mientras que los pacientes que se encontraban en hemodiálisis tuvieron menor probabilidad.
Background:
In Mexico 130,000 people live with chronic kidney disease (CKD). Heart conditions are the most frequent clinical problems; 45% of the deaths of patients in replacement therapy have a cardiac origin. Objective:
To identify the probability of presenting acute heart failure (AHF) in patients with CKD in the Adult Emer- gency Department (AED) of a second-level hospital. Material and methods:
Case-control study with 111 cases and 103 controls. Cases were defined as patients with CKD admitted to AED for AHF compared with controls:
patients with CKD who were admitted for a different diagnosis. Binary logistic regression was performed and odds ratio (OR) and 95% confidence intervals (95% CI) were determined. A value of p ˂ 0.05 was considered significant. Results:
Arterial hypertension (OR 7.12, 95% CI 2.3-22.06, p = 0.01), the use of 3 or more antihypertensive drugs (OR 2.903, 95% CI 1.19-7.11, p = 0.02), the use of inhibitors of angiotensin converting enzyme (ACE inhibitors) (OR 4.25, 95% CI 1.78-10.09, p = 0.01), angiotensin II receptor blockers (ARBs) (OR 2.41, 95% CI 1.19-4.89, p = 0.014), diuretics (OR 42.87, 95% CI 9.02-203.63,
p = 0.00), peritoneal dialysis (OR 2.48, 95% CI 1.25-4.81, p = 0.009) and hemodialysis (OR 0.40, 95% CI 0.20-0.79, p = 0.009) had statistical significance. Conclusions:
CKD patients with arterial hypertension, use of ACE inhibitors, ARBs, diuretics and peritoneal dialysis were more likely to present AHF, while patients who were on hemodialysis were less likely to presenting it.